These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15824381)

  • 1. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.
    MacIntyre CR; Kelly H; Jolley D; Butzkueven H; Salmon D; Halsey N; Moulton LH
    Neurology; 2005 Apr; 64(7):1317; author reply 1318. PubMed ID: 15824381
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.
    DeStefano F; Weintraub ES; Chen RT
    Neurology; 2005 Apr; 64(7):1317; author reply 1318. PubMed ID: 15832457
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the hepatitis B vaccine cause multiple sclerosis?
    Naismith RT; Cross AH
    Neurology; 2004 Sep; 63(5):772-3. PubMed ID: 15365121
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
    Braillon A; Dubois G
    Neurology; 2009 Jun; 72(23):2053. PubMed ID: 19506233
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against hepatitis B and the risk of multiple sclerosis].
    Magdzik W; Zieliński A
    Przegl Epidemiol; 2005; 59(1):11-9. PubMed ID: 16013405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry?
    Faure E
    Med Hypotheses; 2005; 65(3):509-20. PubMed ID: 15908138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China.
    Yang S; Ma X; Ni H; Zhou S; Hu D; Shi H; Chen X; Dong H; Xu G
    Hum Vaccin Immunother; 2015; 11(12):2819-26. PubMed ID: 26211419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demyelinating disease and hepatitis B vaccination: is there a link?
    Jefferson T; Heijbel H
    Drug Saf; 2001; 24(4):249-54. PubMed ID: 11330654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?
    Mormile R
    Immunol Lett; 2015 May; 165(1):60-1. PubMed ID: 25794632
    [No Abstract]   [Full Text] [Related]  

  • 12. Problems in the interpretation of serological results of hepatitis B testing during an incident of hepatitis B virus reactivation in a dialysis unit.
    Fitzpatrick F; Crean M; Kaminski G; Connell J; Thornton L; Murphy N; Brennan A; Walsh J; Humphreys H; Smyth E
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1417-8. PubMed ID: 17994526
    [No Abstract]   [Full Text] [Related]  

  • 13. Extraction and purification of hepatitis B virus-like M particles from a recombinant Saccharomyces cerevisiae strain using alumina powder.
    Hadiji-Abbes N; Martin M; Benzina W; Karray-Hakim H; Gergely C; Gargouri A; Mokdad-Gargouri R
    J Virol Methods; 2013 Jan; 187(1):132-7. PubMed ID: 23059550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
    Le Houézec D
    Immunol Res; 2014 Dec; 60(2-3):219-25. PubMed ID: 25395338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Hepatitis, the vaccine, multiple sclerosis and lichen": the story and its morale].
    Lacour JP
    Ann Dermatol Venereol; 1998 Jul; 125(6-7):395-7. PubMed ID: 9747293
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.
    Hernán MA; Jick SS; Olek MJ; Jick H
    Neurology; 2004 Sep; 63(5):838-42. PubMed ID: 15365133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded programme on immunization (EPI). Lack of evidence that hepatitis B vaccine causes multiple sclerosis.
    Wkly Epidemiol Rec; 1997 May; 72(21):149-52. PubMed ID: 9175481
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of chronic hepatitis B infection in a hepatitis B vaccine responder.
    Sadlier C; Madden K; O'Gorman S; Crowley B; Bergin C
    Int J STD AIDS; 2017 Apr; 28(5):526-528. PubMed ID: 28266264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccine and risk of multiple sclerosis.
    DeStefano F; Verstraeten T; Chen RT
    Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.